0
Article |

Varicella FREE

JOHN Z. SULLIVAN-BOLYAI, MD, MPH; ARNOLD L. SMITH, MD
Am J Dis Child. 1981;135(10):895. doi:10.1001/archpedi.1981.02130340007003.
Text Size: A A A
Published online

There have been several important immunologic and chemotherapeutic advances in the treatment and prevention of primary varicella infection over the past decade. By contrast, data of equivalent quality that define the population that may benefit from these interventions and the morbidity and mortality due to primary and recurrent varicella virus infection are not available. The article by Fleischer et al in this issue of the Journal (see p 896) increases our fund of knowledge on the morbidity and mortality.

Most susceptible patients who receive Herpes zoster-immune globulin within 72 hours of primary exposure to varicella virus have a clinical course milder than expected.1-3 Human leukocyte interferon administered within 48 hours after the appearance of the exanthem also attenuates the disease.4 In a recent double-blind, placebo-control study, pre-exposure therapy with transfer factor in immunocompromised patients decreased the morbidity of primary varicella virus infection.5

Antiviral drugs, such as

REFERENCES

Gershon AA, Steinberg S, Brunell PA:  Zoster immune globulin: A further assessment . N Engl J Med 1974;;290:243-245.
Judelsohn RG, Myers JD, Ellis RJ, et al:  Efficacy of zoster immune globulin . Pediatrics 1974;;53:476-480.
Evans EB, Pollack TM, Cradock-Watson JE, et al:  Human anti-chickenpox immunoglobulin in the prevention of chickenpox . Lancet 1980;;1:354-356.
Arvin AM, Feldman S, Merigan TC:  Human leukocyte interferon in the treatment of varicella in children with cancer: A preliminary controlled trial . Antimicrob Agents Chemother 1978;;13:605-607.
Steele RW, Myers MG, Vincent MM:  Transfer factor for the prevention of varicella-zoster infection in childhood leukemia . N Engl J Med 1980;;303:355-359.
Hirsch MS, Swartz MN:  Drug therapy: Antiviral agents . N Engl J Med 1980;;302:903-907, 949-953.
Brunell PA:  Protection against varicella . Pediatrics 1977;;59:1-2.
Brunell PA:  Brunell's brush-off . Pediatrics 1977;;59:954.
Brunell PA:  Varicella zoster virus vaccine . JAMA 1978;;239:1034-1035.
Gershon AA:  Varicella-zoster virus: Prospects for active immunization . Am J Clin Pathol 1978;;70:170-174.
Kempe CH, Gershon AA:  Varicella vaccine at the crossroads . Pediatrics 1977;;70:930-931.
Plotkin SA:  Varicella vendetta: Plotkin's plug . Pediatrics 1977;;59:953-954.
Sabin AS:  Varicella-zoster virus vaccine . JAMA 1977;;238:1731-1733.
Asano Y, Takahashi M:  Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children . Pediatrics 1977;;60:810-814.
Baba K, Yabuuchi H, Okuni H, et al:  Studies with live varicella vaccine and inactivated skin test antigen: Protective effect of the vaccine and clinical application of the skin test . Pediatrics 1978;;61:550-555.
Ha K, Baba H, Ikeda T, et al:  Application of live varicella vaccine to children with acute leukemia or other malignancies without suspension of anticancer therapy . Pediatrics 1980;; 65:346-350.
Izawa T, Ihara T, Hattori A, et al:  Application of a live varicella vaccine in children with acute leukemia or other malignant diseases . Pediatrics 1977;;60:805-809.
Preblud SR, D'Angelo LJ:  Chickenpox in the United States, 1972-1977 . J Infect Dis 1979;;140:257-259.
Weller TH:  Varicella-herpes zoster virus , in Evans AS (ed): Viral Infections of Humans . New York, Plenum Press Inc, 1976;, pp 462-463.
Feldman S, Hughes WT, Daniel CB:  Varicella in children with cancer: Seventy-seven cases . Pediatrics 1975;;56:388-397.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Gershon AA, Steinberg S, Brunell PA:  Zoster immune globulin: A further assessment . N Engl J Med 1974;;290:243-245.
Judelsohn RG, Myers JD, Ellis RJ, et al:  Efficacy of zoster immune globulin . Pediatrics 1974;;53:476-480.
Evans EB, Pollack TM, Cradock-Watson JE, et al:  Human anti-chickenpox immunoglobulin in the prevention of chickenpox . Lancet 1980;;1:354-356.
Arvin AM, Feldman S, Merigan TC:  Human leukocyte interferon in the treatment of varicella in children with cancer: A preliminary controlled trial . Antimicrob Agents Chemother 1978;;13:605-607.
Steele RW, Myers MG, Vincent MM:  Transfer factor for the prevention of varicella-zoster infection in childhood leukemia . N Engl J Med 1980;;303:355-359.
Hirsch MS, Swartz MN:  Drug therapy: Antiviral agents . N Engl J Med 1980;;302:903-907, 949-953.
Brunell PA:  Protection against varicella . Pediatrics 1977;;59:1-2.
Brunell PA:  Brunell's brush-off . Pediatrics 1977;;59:954.
Brunell PA:  Varicella zoster virus vaccine . JAMA 1978;;239:1034-1035.
Gershon AA:  Varicella-zoster virus: Prospects for active immunization . Am J Clin Pathol 1978;;70:170-174.
Kempe CH, Gershon AA:  Varicella vaccine at the crossroads . Pediatrics 1977;;70:930-931.
Plotkin SA:  Varicella vendetta: Plotkin's plug . Pediatrics 1977;;59:953-954.
Sabin AS:  Varicella-zoster virus vaccine . JAMA 1977;;238:1731-1733.
Asano Y, Takahashi M:  Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children . Pediatrics 1977;;60:810-814.
Baba K, Yabuuchi H, Okuni H, et al:  Studies with live varicella vaccine and inactivated skin test antigen: Protective effect of the vaccine and clinical application of the skin test . Pediatrics 1978;;61:550-555.
Ha K, Baba H, Ikeda T, et al:  Application of live varicella vaccine to children with acute leukemia or other malignancies without suspension of anticancer therapy . Pediatrics 1980;; 65:346-350.
Izawa T, Ihara T, Hattori A, et al:  Application of a live varicella vaccine in children with acute leukemia or other malignant diseases . Pediatrics 1977;;60:805-809.
Preblud SR, D'Angelo LJ:  Chickenpox in the United States, 1972-1977 . J Infect Dis 1979;;140:257-259.
Weller TH:  Varicella-herpes zoster virus , in Evans AS (ed): Viral Infections of Humans . New York, Plenum Press Inc, 1976;, pp 462-463.
Feldman S, Hughes WT, Daniel CB:  Varicella in children with cancer: Seventy-seven cases . Pediatrics 1975;;56:388-397.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.